1
|
Alshafie M, Bitar A, Alfawal M, Alameer MB, Alhomsi D, Saifo M. Breast self-examination among female medical students at Damascus University: A cross-sectional study. Heliyon 2024; 10:e35312. [PMID: 39165947 PMCID: PMC11334666 DOI: 10.1016/j.heliyon.2024.e35312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/12/2023] [Revised: 07/24/2024] [Accepted: 07/26/2024] [Indexed: 08/22/2024] Open
Abstract
Introduction Breast cancer (BC) is the leading cause of death in Syria. In young females, it is a serious complication, making it crucial to raise awareness about the disease and its early detection methods. Given the challenging circumstances that Syrians face, regular visits to medical centers for mammography are often not feasible. Therefore, breast self-examination (BSE) is a valuable tool for detecting cancer. Educating girls in medical colleges is key to disseminating knowledge about BSE among women, as they will become future healthcare providers and can share accurate information with their families. Materials and methods A cross-sectional study was conducted in the medical faculties of Damascus University (medicine, dentistry, and pharmacy), Syria. The study utilized a structured questionnaire on Google Forms with four sections. The questionnaire was prepared electronically, and shared as an online link in formal university groups on social media. Data collection started on September 19, 2022, and ended on October 19 of the same year. Participation was accepted from female students in medical colleges, ranging from second to fifth year (for dental and pharmacy students) and sixth year (for medical students). Data from other students and incomplete data were excluded. Results 589 female medical students from three faculties (medicine, dentistry, and pharmacy) filled out the questionnaire. Only 57 % of the students demonstrated a good attitude towards BSE, and 79.6 % of them agreed or strongly agreed that they avoid BSE due to fear of the consequences of breast cancer. Regarding BSE knowledge, 89.6 % of the participants reported previously hearing about BSE, and 55.7 % of them had performed BSE before. The factors that were accompanied by better knowledge about BSE were: a good attitude towards BSE; previously performed BSE; studying in a medical faculty; study years for medical and pharmacy students; and higher college average grades. Whereas, having a medical relative and having a family member with a history of BC surprisingly do not impact the knowledge. Conclusion The study, conducted at Damascus University in Syria, assessed the knowledge and practice of breast self-examination among female medical college students. The results indicate a moderate level of knowledge and limited practical experience in performing breast self-examination. These findings highlight the urgent need to emphasize the importance of promoting and teaching this method to a wider population of women in society.
Collapse
Affiliation(s)
- Mohammed Alshafie
- Medical Student in Medicine, Faculty of Medicine, Damascus University, Damascus, Syria
| | - Anas Bitar
- Medical Student in Medicine, Faculty of Medicine, Damascus University, Damascus, Syria
| | - Massa Alfawal
- Medical Student in Medicine, Faculty of Medicine, Damascus University, Damascus, Syria
| | - Mhd Basheer Alameer
- Medical Student in Medicine, Faculty of Medicine, Damascus University, Damascus, Syria
| | - Dima Alhomsi
- Medical Student in Medicine, Faculty of Medicine, Damascus University, Damascus, Syria
| | - Maher Saifo
- Professor of Medical Oncology, Vice Dean for Scientific Affairs, Faculty of Medicine, Damascus University, Almazzeh, Damascus, Syria
| |
Collapse
|
2
|
Alshafie M, Soqia J, Alhomsi D, Alameer MB, Yakoub-Agha L, Saifo M. Knowledge and practice of breast self-examination among breast cancer patients in Damascus, Syria. BMC Womens Health 2024; 24:73. [PMID: 38281922 PMCID: PMC10822174 DOI: 10.1186/s12905-024-02912-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2023] [Accepted: 01/17/2024] [Indexed: 01/30/2024] Open
Abstract
BACKGROUND Breast cancer (BC) represents an important cause of cancer death, its incidence rate has been rising gradually in the Arab world, and in Syria, BC is the most common cancer and the leading cause of cancer death; its prognosis gets better as we detect it early in its first stages. So, it is very important to implement one or more early detection methods such as Breast Self-Examination (BSE), Clinical Breast Examination (CBE), and mammography. BSE represents an effective method to find out changes in breast structure when they happen. This study investigates the knowledge of BSE and its practice in BC patients. METHODS A quantitative cross-sectional study in Al-Bairouni hospital in Damascus-Syria was carried out using face-to-face interviews based on a structured questionnaire, which consisted of 4 sections. The data were subjected to statistical analysis using various analytical tests, including the independent t-test, one-way analysis of variance (ANOVA), and Chi-square test. RESULTS Five hundred patients were interviewed. Only 27.4% of patients had a good knowledge of BSE, 17.4% had average knowledge, and 55.2% had low knowledge of BSE. The factors that have an impact on the knowledge of BSE were: family breast cancer history (first and second-degree relatives), education, and the region of living (between governorates). The effect of knowledge of BSE on its practice was positive. However, only 24.8% of patients have been practicing BSE; the reasons for not practicing BSE were: no one has told the patient about it (64.8% of cases), and the patient does not have any symptoms relating to the breast (21.4%).Breast cancer was identified through breast self-examination (BSE) in 15.6% of cases. CONCLUSION There is a low degree of knowledge and little practice of BSE among Syrian breast cancer patients. Family breast cancer history, governate, occupation, and level of education had a statistically significant effect on knowledge scores of BSE, unlike age and social status. So, some steps should be taken to increase awareness about BSE among Syrian females.
Collapse
Affiliation(s)
- Mohammed Alshafie
- Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic.
| | - Jameel Soqia
- Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic
| | - Dima Alhomsi
- Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic
| | | | - Laila Yakoub-Agha
- Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic
| | - Maher Saifo
- Faculty of Medicine, Damascus University, Damascus, Syrian Arab Republic
| |
Collapse
|
3
|
Basudan AM. Breast Cancer Incidence Patterns in the Saudi Female Population: A 17-Year Retrospective Analysis. MEDICINA (KAUNAS, LITHUANIA) 2022; 58:medicina58111617. [PMID: 36363574 PMCID: PMC9697748 DOI: 10.3390/medicina58111617] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/04/2022] [Revised: 10/30/2022] [Accepted: 11/07/2022] [Indexed: 11/12/2022]
Abstract
Background and Objectives: Breast cancer is considered the most commonly diagnosed type of cancer among women globally and in Saudi Arabia. This study aimed to assess breast cancer incidence patterns and trends among the Saudi female population. Materials and Methods: Breast cancer incidence parameters were obtained from the Saudi Cancer Registry (SCR). The data were retrospectively analyzed for the period from 2001 to 2017 to investigate changes in incidence rates. Temporal trends were also analyzed through joinpoint regression analysis and were dissected by age groups and administrative regions. Results: During the specified period, breast cancer jumped by 55% to constitute 30.9% of all cancer cases among Saudi females. The median age at diagnosis increased to reach 51 years at the end of that period, with an overall increase of 6.3%. The overall Age-Standardized Incidence Rate (ASR) escalated by 151.7% from 11.8/100,000 to 29.7/100,000 population for that period. The Eastern region noticeably had the highest ASR and peaked at 52.2/100,000 population. The joinpoint analysis of the ASR showed increased trends, with an annual percent change (APC) of 5.13% (p < 0.05, [95% CI 4−6.3]). An age-specific analysis was also performed and showed that the age group 70−74 years had the highest trend (APC 10.2%, [95% CI 7.2−13.4], p < 0.05). Region-specific analysis revealed that the Jouf region had the highest trend among the regions (APC 8.8%, [95% CI 3.7−14.2], p < 0.05). Conclusions: Our analysis indicates increased breast cancer incidence in Saudi Arabia with an alarming pace. With the existing trend, it is expected that Saudi Arabia will continue to display an increase in breast cancer incidence. Long-term preventive measures and more effective screening strategies are warranted to alleviate the burden of the disease.
Collapse
Affiliation(s)
- Ahmed M Basudan
- Chair of Medical and Molecular Genetics Research, Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, Riyadh 12372, Saudi Arabia
| |
Collapse
|
4
|
Clinical Significance of Breast Cancer Molecular Subtypes and Ki67 Expression as a Predictive Value for Pathological Complete Response following Neoadjuvant Chemotherapy: Experience from a Tertiary Care Center in Lebanon. Int J Breast Cancer 2022; 2022:1218128. [PMID: 35190777 PMCID: PMC8858059 DOI: 10.1155/2022/1218128] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2021] [Revised: 01/04/2022] [Accepted: 01/27/2022] [Indexed: 11/25/2022] Open
Abstract
Introduction Breast cancer is considered nowadays the most prevalent cancer worldwide. The molecular era has successfully divided breast cancer into subtypes based on the various hormonal receptors. These molecular subtypes play a major role in determining the neoadjuvant chemotherapy to be administered. It was noted that the use of neoadjuvant chemotherapy was associated with higher achievement of pathological complete response. The aim of the study was to determine the predictive role of breast cancer subtypes in the efficacy and prognosis of neoadjuvant chemotherapy regimens. Methods Combining dose dense anthracycline-based, regular dose anthracycline-based, and nonanthracycline-based chemotherapy, we observed data from 87 patients with breast cancer who received surgery after administration of neoadjuvant chemotherapy at our institution between January 2015 and July 2018. The patients were classified into luminal A, luminal B, HER2 overexpression, and triple negative breast cancer as well as low Ki67 (≤14%) and high Ki67 (>14%) expression groups using immunohistochemistry. Pathologic complete response was the only neoadjuvant chemotherapy outcome parameter. To evaluate variables associated with pathologic complete response, we used univariate analyses followed by multivariate logistic regression. Results 87 patients with breast cancer were classified into different subtypes according to the 12th St. Gallen International Breast Cancer Conference. The response rate to neoadjuvant chemotherapy was significantly different (p = 0.046) between the subgroups. There were significant correlations between pathological complete response (pCR) and ER status (p < 0.0001), HER2 (p = 0.013), molecular subtypes (p = 0.018), T stage (p = 0.024), N stage before chemotherapy (p = 0.04), and type of chemotherapy (p = 0.029). Luminal B type patients had the lowest pCR, followed by luminal A type patients. Conclusion Evaluating molecular subtype's significance in breast cancer prognosis warrants additional studies in our region with extensive data about patient-specific neoadjuvant chemotherapy regimens. Our study was able to reproduce results complementary to those present in the literature in other outcomes.
Collapse
|
5
|
Frequency and clinical characteristics of HER2 over-expressed breast cancer in Saudi Arabia: a retrospective study. BMC WOMENS HEALTH 2021; 21:10. [PMID: 33407382 PMCID: PMC7788710 DOI: 10.1186/s12905-020-01159-3] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/20/2020] [Accepted: 12/23/2020] [Indexed: 12/24/2022]
Abstract
INTRODUCTION This study aimed to determine the frequency of human epidermal growth factor receptor 2 (HER2) over-expression in newly diagnosed breast cancer (BC) patients in Saudi Arabia and to assess the clinical characteristics and outcomes in patients with HER2-positive disease. METHODS In the first part of the study, we retrospectively reviewed the pathology records of all patients diagnosed with BC between 2007 and 2013 at 3 hospitals in the largest 3 cities in Saudi Arabia to determine the frequency of HER2 over-expression. In the second part, a representative sample from the patients identified with HER2 over-expressed BC was selected for further investigation. Data collected included demographic and clinical characteristics such as hormone-receptor status, treatment regimens, survival data, response to treatment, and selected adverse events. RESULTS 1867 BC records were included in the study. HER2 was overexpressed in 559 patients (29.9%); of those, 348 HER2-positive BC patients were included in subsequent analyses. In the sample of HER2-positive BC patients, median age at diagnosis was 46 years, 0.9% were male, 92.5% were Saudi, 42.4% were Hormone Receptor-negative, and 13.1% had stage IV tumors. Most patients (84.2%) underwent curative intent surgery and 71.8% received radiotherapy. Average tumor size was 3.5 ± 2.5 cm and infiltrating ductal carcinoma was the most common pathology (92.9%). As for pharmacological therapy, the most commonly used regimens were Chemotherapy + Trastuzumab combination (79.1%) in neoadjuvant setting, Hormonotherapy alone (56.2%) in adjuvant setting, and Chemotherapy + Targeted therapy combination (64.8%) as palliative treatment. At the last patient evaluation, 36.9% had complete response, while 33.2% had progressive disease. Median overall survival (OS) and progression-free survival (PFS) were not reached in patients on neoadjuvant/adjuvant pharmacotherapy. As for patients on palliative intent pharmacotherapy, median OS and PFS were 64.7 and 29.3 months respectively. CONCLUSION This study provided updated figures regarding HER2 overexpression in BC in Saudi Arabia: HER2 overexpression rate (29.9%) was within the range reported in previous studies. Patients' demographic and clinical characteristics were also similar to those reported earlier, with a median age at diagnosis of 46 years and one third of patients having locally advanced/metastatic disease at diagnosis.
Collapse
|
6
|
El Khoury CJ, Adib SM, Chaaya M, El Asmar K, Charafeddine M, El-Saghir NS. Trends in Breast Cancer Staging at Diagnosis Associated with Screening Campaigns in Lebanon. WOMEN'S HEALTH REPORTS (NEW ROCHELLE, N.Y.) 2020; 1:521-528. [PMID: 33786518 PMCID: PMC7785066 DOI: 10.1089/whr.2020.0076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Accepted: 09/21/2020] [Indexed: 11/26/2022]
Abstract
Introduction: Mammography screening has been shown to improve early breast cancer (BC) detection, by shifting the disease at diagnosis to locally confined stages, offering lighter treatments and better prognoses. BC awareness campaigns calling for annual mammography screenings have been ongoing in Lebanon since 2002. Changes in BC staging at diagnosis as a consequence of documented improvements in mammography uptake remain to be described. Materials and Methods: We reviewed 2,822 BC cases identified by pathology reports in the American University of Beirut Medical Center between the years 1990 and 2015. After age stratification, we have trended the extracted stages versus time. Results were compared between the prescreening (1990-2001) and the postscreening period (2002-2015). Results: During the postscreening period, stage I represented 31%, stage II 47%, stage III 14%, and stage IV 8% of the cases. Stage I cases had more than doubled whereas stage III cases showed a mirror decrease compared with the years before the implementation of awareness campaigns. The increase in stage I was significantly more prominent in women aged 40 years and older (from 14% to 32%), compared with the younger group. Shifts in staging happened in parallel with a concurrent rise in reported uptake of mammography screening. Conclusions: Our findings demonstrate significant trends in earlier detection, which are likely associated with an increase in screening uptake and an awareness of BC as a public health issue. Staging data from hospitals all over Lebanon should be available for building national evidence. The Ministry of Public Health should require reporting of BC stage at diagnosis to the National Cancer Registry, as part of the annual cancer incidence reporting in Lebanon.
Collapse
Affiliation(s)
- Christiane J. El Khoury
- Department of Epidemiology and Population Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon
| | - Salim M. Adib
- Department of Epidemiology and Population Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon
| | - Monique Chaaya
- Department of Epidemiology and Population Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon
| | - Khalil El Asmar
- Department of Epidemiology and Population Health, Faculty of Health Sciences, American University of Beirut, Beirut, Lebanon
| | - Maya Charafeddine
- Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
| | - Nagi S. El-Saghir
- Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
| |
Collapse
|
7
|
Mahumud RA, Gow J, Keramat SA, March S, Dunn J, Alam K, Renzaho AMN. Distribution and predictors associated with the use of breast cancer screening services among women in 14 low-resource countries. BMC Public Health 2020; 20:1467. [PMID: 32993596 PMCID: PMC7526143 DOI: 10.1186/s12889-020-09557-w] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2019] [Accepted: 09/17/2020] [Indexed: 12/27/2022] Open
Abstract
BACKGROUND Breast cancer is one of the leading public health problem globally, especially in low-resource countries (LRCs). Breast cancer screening (BCS) services are an effective strategy for early determining of breast cancer. Hence, it is imperative to understand the utilisation of BCS services and their correlated predictors in LRCs. This study aims to determine the distribution of predictors that significantly influence the utilisation of BCS services among women in LRCs. METHODS The present study used data on 140,974 women aged 40 years or over from 14 LRCs. The data came from country Demographic and Health Surveys (DHS) between 2008 and 2016. Multivariate logistic regression analysis was employed to investigate the significant predictors that influence the use of BCS services. RESULTS The utilisation of BCS services was 15.41%, varying from 81.10% (95% CI: 76.85-84.73%) in one European country, to 18.61% (95% CI: 18.16 to 19.06%) in Asian countries, 14.30% (95% CI: 13.67-14.96%) in American countries, and 14.29% (95% CI: 13.87-14.74%). Factors that were significantly associated to increase the use of BCS services include a higher level of education (OR = 2.48), advanced age at first birth (> 25 years) (OR = 1.65), female-headed households (OR = 1.65), access to mass media communication (OR = 1.84), health insurance coverage (OR = 1.09), urban residence (OR = 1.20) and highest socio-economic status (OR = 2.01). However, obese women shown a significantly 11% (OR = 0.89) lower use of BSC services compared to health weight women. CONCLUSION The utilisation of BCS services is low in many LRCs. The findings of this study will assist policymakers in identifying the factors that influence the use of BCS services. To increase the national BCS rate, more attention should be essential to under-represented clusters; in particular women who have a poor socioeconomic clusters, live in a rural community, have limited access to mass media communication, and are have a low level educational background. These factors highlight the necessity for a new country-specific emphasis of promotional campaigns, health education, and policy targeting these underrepresented groups in LRCs.
Collapse
Affiliation(s)
- Rashidul Alam Mahumud
- School of Social Sciences, Western Sydney University, Penrith, New South Wales, 2751, Australia.
- Translational Health Research Institute (THRI), Western Sydney University, Sydney, New South Wales, Australia.
- Health Economics and Policy Research, School of Commerce, Centre for Health Research, University of Southern Queensland, Toowoomba, Queensland, 4350, Australia.
| | - Jeff Gow
- Health Economics and Policy Research, School of Commerce, Centre for Health Research, University of Southern Queensland, Toowoomba, Queensland, 4350, Australia
- School of Accounting, Economics and Finance, University of KwaZulu-Natal, Durban, 4000, South Africa
| | - Syed Afroz Keramat
- Department of Economics, American International University-Bangladesh, Dhaka, 1212, Bangladesh
| | - Sonja March
- School of Psychology and Counselling, University of Southern Queensland, Toowoomba, Queensland, 4300, Australia
| | - Jeff Dunn
- Health Economics and Policy Research, School of Commerce, Centre for Health Research, University of Southern Queensland, Toowoomba, Queensland, 4350, Australia
- Cancer Research Centre, Cancer Council Queensland, Fortitude Valley, Brisbane, QLD 4006, Australia
- Prostate Cancer Research Foundation of Australia, St Leonards, New South Wales, 2065, 40, Australia
| | - Khorshed Alam
- Health Economics and Policy Research, School of Commerce, Centre for Health Research, University of Southern Queensland, Toowoomba, Queensland, 4350, Australia
| | - Andre M N Renzaho
- School of Social Sciences, Western Sydney University, Penrith, New South Wales, 2751, Australia
- Translational Health Research Institute (THRI), Western Sydney University, Sydney, New South Wales, Australia
| |
Collapse
|
8
|
Fares MY, Salhab HA, Khachfe HH, Khachfe HM. Breast Cancer Epidemiology among Lebanese Women: An 11-Year Analysis. MEDICINA (KAUNAS, LITHUANIA) 2019; 55:E463. [PMID: 31405167 PMCID: PMC6723716 DOI: 10.3390/medicina55080463] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/31/2019] [Revised: 07/20/2019] [Accepted: 08/08/2019] [Indexed: 02/06/2023]
Abstract
Background and Objectives: Breast cancer is the most prevalent cancer in women worldwide. Lebanon is a developing country in the Middle East with a prominent breast cancer incidence. The aim of our study was to explore the incidence rates of breast cancer in Lebanon from 2005 to 2015, and compare them to the rates of other countries. Materials and Methods: Breast cancer data for the years 2005-2015 was collected from the National Cancer Registry of Lebanon and stratified by gender and age group. Age-specific and age-standardized incidence rates were calculated and analyzed using joinpoint regression. Age-standardized incidence rates in the world population (ASR(w)) were obtained for other countries, from two online databases. Results: Breast cancer was found to be the most prevalent cancer in Lebanon, accounting for 20% of all cancer cases. The average ASR(w) was 96.5 per 100,000. Over the studied period, breast cancer ASR(w) in Lebanon showed a significantly increasing trend with an annual percent change (APC) of +4.6. Moreover, the APC of breast cancer age-specific rates significantly increased for the age groups 45-49 (p = 0.013), 50-54 (p < 0.001), 55-59 (p = 0.001), 60-64 (p = 0.002), 65-69 (p = 0.003), 70-74 (p < 0.001), and 75+ years (p < 0.001). Lebanon had the highest breast cancer ASR(w), when compared to other regional countries, and trailed only behind Denmark, when compared to selected countries from different parts of the world. Conclusions: Breast cancer incidence in Lebanon is among the highest in the world. Future studies should focus on exploring the genetic profile of the Lebanese population in an aim to extrapolate proper prevention guidelines.
Collapse
Affiliation(s)
- Mohamad Y Fares
- Faculty of Medicine, American University of Beirut, Beirut 1107, Lebanon.
- Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut 1102, Lebanon.
| | - Hamza A Salhab
- Faculty of Medicine, American University of Beirut, Beirut 1107, Lebanon
- Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut 1102, Lebanon
| | - Hussein H Khachfe
- Faculty of Medicine, American University of Beirut, Beirut 1107, Lebanon
- Neuroscience Research Center, Faculty of Medical Sciences, Lebanese University, Beirut 1102, Lebanon
| | - Hassan M Khachfe
- School of Arts and Sciences, and the Lebanese Institute for Biomedical Research and Application (LIBRA), Lebanese International University (LIU), Beirut 1105, Lebanon
| |
Collapse
|
9
|
Abrao Nemeir I, Saab J, Hleihel W, Errachid A, Jafferzic-Renault N, Zine N. The Advent of Salivary Breast Cancer Biomarker Detection Using Affinity Sensors. SENSORS (BASEL, SWITZERLAND) 2019; 19:E2373. [PMID: 31126047 PMCID: PMC6566681 DOI: 10.3390/s19102373] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 04/15/2019] [Revised: 05/09/2019] [Accepted: 05/20/2019] [Indexed: 12/14/2022]
Abstract
Breast Cancer is one of the world's most notorious diseases affecting two million women in 2018 worldwide. It is a highly heterogeneous disease, making it difficult to treat. However, its linear progression makes it a candidate for early screening programs, and the earlier its detection the higher the chance of recovery. However, one key hurdle for breast cancer screening is the fact that most screening techniques are expensive, time-consuming, and cumbersome, making them impractical for use in several parts of the world. One current trend in breast cancer detection has pointed to a possible solution, the use of salivary breast cancer biomarkers. Saliva is an attractive medium for diagnosis because it is readily available in large quantities, easy to obtain at low cost, and contains all the biomarkers present in blood, albeit in lower quantities. Affinity sensors are devices that detect molecules through their interactions with biological recognition molecules. Their low cost, high sensitivity, and selectivity, as well as rapid detection time make them an attractive alternative to traditional means of detection. In this review article, we discuss the current status of breast cancer diagnosis, its salivary biomarkers, as well as the current trends in the development of affinity sensors for their detection.
Collapse
Affiliation(s)
- Imad Abrao Nemeir
- Faculty of Sciences, Holy Spirit University of Kaslik, 446 Jounieh, Mount Lebanon, Lebanon.
- Institut des Sciences Analytiques, Université de Lyon, Claude Bernard Lyon 1, UMR 5280, CNRS - 5, rue de la Doua, 69100 Villeurbanne, France.
| | - Joseph Saab
- Faculty of Sciences, Holy Spirit University of Kaslik, 446 Jounieh, Mount Lebanon, Lebanon.
| | - Walid Hleihel
- Faculty of Sciences, Holy Spirit University of Kaslik, 446 Jounieh, Mount Lebanon, Lebanon.
| | - Abdelhamid Errachid
- Institut des Sciences Analytiques, Université de Lyon, Claude Bernard Lyon 1, UMR 5280, CNRS - 5, rue de la Doua, 69100 Villeurbanne, France.
| | - Nicole Jafferzic-Renault
- Institut des Sciences Analytiques, Université de Lyon, Claude Bernard Lyon 1, UMR 5280, CNRS - 5, rue de la Doua, 69100 Villeurbanne, France.
| | - Nadia Zine
- Institut des Sciences Analytiques, Université de Lyon, Claude Bernard Lyon 1, UMR 5280, CNRS - 5, rue de la Doua, 69100 Villeurbanne, France.
| |
Collapse
|
10
|
Assi T, Bakouny Z, Labaki C, El Rassy E, Khazzaka A, Jabbour R, Haddad FG, Tohme A, El Karak F, Ghosn M, Kattan J. Causes of death in older patients with cancer: Experience of a tertiary care center in Lebanon. J Geriatr Oncol 2019; 10:365-367. [DOI: 10.1016/j.jgo.2018.10.017] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2018] [Revised: 09/09/2018] [Accepted: 10/24/2018] [Indexed: 11/30/2022]
|
11
|
Abood RA. Breast Cancer in Basra Oncology Center: A Clinico- Epidemiological Analysis. Asian Pac J Cancer Prev 2018; 19:2943-2946. [PMID: 30362328 PMCID: PMC6291032 DOI: 10.22034/apjcp.2018.19.10.2943] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/20/2018] [Accepted: 09/08/2018] [Indexed: 12/21/2022] Open
Abstract
Background: Breast cancer is the most common cancer affecting women, and the leading cause of cancer-related deaths. Objective: This study was performed to evaluate clinico-epidemiological features of breast cancer from Iraq during a five-year period. Methodology: This is a retrospective descriptive study. Medical notes and histopathological reports of patients with confirmed diagnosis of breast cancer between January 2011 and December 2015 were reviewed for age, gender, site, laterality, histopathological type, grade of differentiation and TNM stage at diagnosis. Results: A total of 1,000 patients were included in the study. Mean age at diagnosis was 50 years (range 22-85 years), and females constituted 99.2% of cases. Most cases (98.7%) were unilateral and most common (85.5%) histological subtype was invasive ductal carcinoma. Majority of the cases (58%) were moderately differentiated (grade II), wherein 45% belonged to stage II in TNM system, and nearly half (49%) of patients had locally advanced or metastatic cancer. Conclusion: Breast cancer presents at least a decade earlier and at a more advanced stage in Iraqi women when compared to the Western World. Steps for early detection are essential for initiation of prompt therapy and reduction of mortality.
Collapse
Affiliation(s)
- Rafid A Abood
- Basra College of Medicine, Basra, Iraq
- Basra Oncology Center, Basra, Iraq.
| |
Collapse
|
12
|
Rassy EE, Chebly A, Korban R, Semaan W, Bakouny Z, Assi T, Kourie HR, Karak FE, Chouery E, Kattan J. Untreated chronic lymphocytic leukemia in Lebanese patients: an observational study using standard karyotyping and FISH. Int J Hematol Oncol 2017; 6:105-111. [PMID: 30302231 PMCID: PMC6172003 DOI: 10.2217/ijh-2017-0019] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2017] [Accepted: 09/27/2017] [Indexed: 01/04/2023] Open
Abstract
AIM We aimed to understand the biology of chronic lymphocytic leukemia (CLL) patients in Lebanon. MATERIALS & METHODS We applied conventional cytogenetic and FISH studies on Lebanese patients diagnosed with CLL and undergoing a watch and wait approach. RESULTS Our study disclosed 53.6% of patients with aberrant karyotypes among which 26.7% were complex karyotypes. Genetic aberrations included del(13q14) 46.4%, 14q32 translocation in 25%, trisomy 12 in 14.3%, del(17p13) and del(11q22) in 7.1% each. The deletion of 6q21/6q23 was not found in any of our patients. CONCLUSION The higher prevalence of del(13q14) as a sole abnormality could be the primary event in inducing CLL. The del(17p13) and del(11q22) followed as potential drivers for progression in CLL patients with a watch and wait approach.
Collapse
Affiliation(s)
- Elie El Rassy
- Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon
| | - Alain Chebly
- Department of Genetics, Unité de Génétique Médicale, Pôle technologie Santé, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon
| | - Rima Korban
- Department of Genetics, Unité de Génétique Médicale, Pôle technologie Santé, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon
| | - Warde Semaan
- Department of Genetics, Unité de Génétique Médicale, Pôle technologie Santé, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon
| | - Ziad Bakouny
- Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon
| | - Tarek Assi
- Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon
| | - Hampig Raphael Kourie
- Department of Genetics, Unité de Génétique Médicale, Pôle technologie Santé, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon
| | - Fadi El Karak
- Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon
| | - Eliane Chouery
- Department of Genetics, Unité de Génétique Médicale, Pôle technologie Santé, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon
| | - Joseph Kattan
- Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Beirut 1104-2020, Lebanon
| |
Collapse
|
13
|
Albeshan SM, Mackey MG, Hossain SZ, Alfuraih AA, Brennan PC. Breast Cancer Epidemiology in Gulf Cooperation Council Countries: A Regional and International Comparison. Clin Breast Cancer 2017; 18:e381-e392. [PMID: 28781021 DOI: 10.1016/j.clbc.2017.07.006] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2017] [Revised: 05/03/2017] [Accepted: 07/09/2017] [Indexed: 01/25/2023]
Abstract
Breast cancer is the most frequently diagnosed noncutaneous malignancy in women living in Gulf Cooperation Council countries. The present report aimed to highlight the similarities and variations in breast cancer incidence, age at diagnosis, clinicopathologic features, molecular characteristics, and lifestyle factors that contribute to an increasing incidence of breast cancer compared with neighboring Arab and westernized countries. The data presented, although having important implications for policy makers, also highlights the need for further research. Such research would ensure that effective prevention and detection strategies are tailored to the specific needs of the Gulf women such that the management of breast cancer is optimized.
Collapse
Affiliation(s)
- Salman M Albeshan
- Medical Radiation Sciences, Medical Image Optimization and Perception Group, University of Sydney, Faculty of Health Sciences, Sydney, NSW, Australia; Department of Radiological Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia.
| | - Martin G Mackey
- Discipline of Physiotherapy, University of Sydney, Faculty of Health Sciences, Sydney, NSW, Australia
| | - Syeda Z Hossain
- Discipline of Behavioral and Social Sciences in Health, University of Sydney, Faculty of Health Sciences, Sydney, NSW, Australia
| | - Abdulrahman A Alfuraih
- Department of Radiological Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Kingdom of Saudi Arabia
| | - Patrick C Brennan
- Medical Radiation Sciences, Medical Image Optimization and Perception Group, University of Sydney, Faculty of Health Sciences, Sydney, NSW, Australia
| |
Collapse
|
14
|
da Costa Vieira RA, Biller G, Uemura G, Ruiz CA, Curado MP. Breast cancer screening in developing countries. Clinics (Sao Paulo) 2017; 72:244-253. [PMID: 28492725 PMCID: PMC5401614 DOI: 10.6061/clinics/2017(04)09] [Citation(s) in RCA: 134] [Impact Index Per Article: 19.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/24/2016] [Accepted: 12/20/2016] [Indexed: 12/14/2022] Open
Abstract
Developing countries have limited healthcare resources and use different strategies to diagnose breast cancer. Most of the population depends on the public healthcare system, which affects the diagnosis of the tumor. Thus, the indicators observed in developed countries cannot be directly compared with those observed in developing countries because the healthcare infrastructures in developing countries are deficient. The aim of this study was to evaluate breast cancer screening strategies and indicators in developing countries. A systematic review and the Population, Intervention, Comparison, Outcomes, Timing, and Setting methodology were performed to identify possible indicators of presentation at diagnosis and the methodologies used in developing countries. We searched PubMed for the terms "Breast Cancer" or "Breast Cancer Screening" and "Developing Country" or "Developing Countries". In all, 1,149 articles were identified. Of these articles, 45 full articles were selected, which allowed us to identify indicators related to epidemiology, diagnostic intervention (diagnostic strategy, diagnostic infrastructure, percentage of women undergoing mammography), quality of intervention (presentation of symptoms at diagnosis, time to diagnosis, early stage disease), comparisons (trend curves, subpopulations at risk) and survival among different countries. The identification of these indicators will improve the reporting of methodologies used in developing countries and will allow us to evaluate improvements in public health related to breast cancer.
Collapse
Affiliation(s)
- René Aloísio da Costa Vieira
- Programa de Pós-Graduação em Oncologia, Hospital de Câncer de Barretos, Barretos, SP, BR
- Programa de Pós-graduação em Obstetricia, Ginecologia e Mastologia, Faculdade de Medicina de Botucatu – UNESP, Botucatu, SP, BR
- *Corresponding author. E-mail:
| | - Gabriele Biller
- Programa de Pós-Graduação em Oncologia, Hospital de Câncer de Barretos, Barretos, SP, BR
| | - Gilberto Uemura
- Programa de Pós-graduação em Obstetricia, Ginecologia e Mastologia, Faculdade de Medicina de Botucatu – UNESP, Botucatu, SP, BR
| | - Carlos Alberto Ruiz
- Departamento de Obstetricia e Ginecologia, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, BR
| | | |
Collapse
|
15
|
Assi T, Nasr F, Rassy EE, Ibrahim T, Jabbour H, Chahine G. Characteristics of Incident Testicular Cancer in Lebanon - 1990-2015 Single Institutional Experience. Asian Pac J Cancer Prev 2017; 17:1899-902. [PMID: 27221873 DOI: 10.7314/apjcp.2016.17.4.1899] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Despite the fact that testicular cancer is a major health issue with its increasing incidence, very few studies have described its characteristics in the Middle East, particularly in Lebanon. MATERIALS AND METHODS We report in this paper a retrospective pilot study of the characteristics of testicular cancer in Lebanon. The demographic, epidemiologic and survival characteristics of 178 patients diagnosed between 1990 and 2015 at an oncology clinic affiliated to Hotel Dieu de France Hospital were analyzed. RESULTS The mean age at diagnosis was 32 ±10 years. The most prevalent testicular tumor was the germ cell type (GCT) (95.2%) of which non-seminomatous tumors (NST) were the commonest (64.7%). Most of our patients were diagnosed at an early stage. Lymph node spread affected most commonly the retroperitoneal region and distant visceral metastases occurred in 14.6%. All patients underwent orchiectomy with 67% receiving adjuvant treatment, mainly chemotherapy. After a median follow up of 2,248 days (75.9 months) 16 patients were reported dead. Two, five and ten-year overall survival rates were 96%, 94% and 89% respectively. The median overall survival rate was not reached. CONCLUSIONS Despite being part of the developing world, demographic, epidemiologic and survival analyses of testicular cancer reported in our study are in line with those reported from developed countries and would allow us to extrapolate management plans from these populations.
Collapse
Affiliation(s)
- Tarek Assi
- Department of Hematology- Oncology, Hotel Dieu de France University Hospital, Faculty of Medicine, Saint Joseph University, Lebanon E-mail :
| | | | | | | | | | | |
Collapse
|